1-methyl-3-isobutylxanthine and bay 73-6691

1-methyl-3-isobutylxanthine has been researched along with bay 73-6691 in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hou, J; Ke, H; Luo, X; Robinson, H; Wang, H; Ye, M	1
de Esch, IJ; de Graaf, C; Jansen, C; Kanev, GK; Kooistra, AJ; Leurs, R	1

Other Studies

2 other study(ies) available for 1-methyl-3-isobutylxanthine and bay 73-6691

Article	Year
Insight into binding of phosphodiesterase-9A selective inhibitors by crystal structures and mutagenesis. Journal of medicinal chemistry, 2010, Feb-25, Volume: 53, Issue:4 Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Catalytic Domain; Crystallography, X-Ray; Humans; Models, Molecular; Mutagenesis, Site-Directed; Mutation; Protein Binding; Protein Conformation; Pyrazoles; Pyrimidines; Stereoisomerism	2010
PDEStrIAn: A Phosphodiesterase Structure and Ligand Interaction Annotated Database As a Tool for Structure-Based Drug Design. Journal of medicinal chemistry, 2016, Aug-11, Volume: 59, Issue:15 Topics: Databases, Protein; Dose-Response Relationship, Drug; Drug Design; Humans; Ligands; Models, Molecular; Molecular Structure; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Structure-Activity Relationship	2016

Article

Year

Insight into binding of phosphodiesterase-9A selective inhibitors by crystal structures and mutagenesis.

Journal of medicinal chemistry, 2010, Feb-25, Volume: 53, Issue:4

Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Catalytic Domain; Crystallography, X-Ray; Humans; Models, Molecular; Mutagenesis, Site-Directed; Mutation; Protein Binding; Protein Conformation; Pyrazoles; Pyrimidines; Stereoisomerism

2010

PDEStrIAn: A Phosphodiesterase Structure and Ligand Interaction Annotated Database As a Tool for Structure-Based Drug Design.

Journal of medicinal chemistry, 2016, Aug-11, Volume: 59, Issue:15

Topics: Databases, Protein; Dose-Response Relationship, Drug; Drug Design; Humans; Ligands; Models, Molecular; Molecular Structure; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Structure-Activity Relationship

2016